Skip to content
Menu

ANI Pharmaceuticals, Inc. ANIP

Full chart Compare
Set alert

Price alert · ANIP

All alert types
69.13 USD -2.34 (-3.27%)

Regular-session close

69.13 0.00 0.00%

After hours · Nov 19, 4:28 PM ET

68.91 Day range 71.10
67.14 52-week range 87.76
YTD
-12.43%
1 year
-13.94%

5D -1.14 (-1.60%)

707172WedThuFriMonTue69.90
Market cap
1.57B
Revenue (ttm)
1.04B
Profit margin
11.22%
EPS (ttm)
4.93
Shares out
22.72M
P/E ratio
14.02
Forward P/E
6.78
YTD return
-12.43%
1-year return
-13.94%
50-day average
72.32
Volume
264.29K
Avg volume
423.52K
Open
70.78
Previous close
71.47
Day's range
68.91 – 71.10
52-week range
67.14 – 87.76
Beta
0.47
Analysts
Buy
Price target
103.38 (+49.5%)
Earnings date
Feb 26, 2027

Key statistics

200-day average
76.86
Enterprise value
1.69B
PEG ratio
1.76
Price / sales
1.51
Price / book
2.32
Revenue growth
27.60%
Free cash flow
184.05M
Total cash
436.97M
Total debt
617.36M
Return on equity
20.45%
Short % of float
19.25%

Fundamental scorecard

18 of 25 checks passed on ANIP’s reported financials

ValueGrowthProfitabilityHealthDividend

18of 25 checks passed

  • Value 4 of 5
  • Growth 5 of 5
  • Profitability 4 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
ANIP Revenue — quarterly 290.78M
ANIP Net income — quarterly 35.15M
ANIP EPS — quarterly 1.54

Earnings

ANIP recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 26, 2027Dec 30, 20262.58———
Nov 5, 2026Sep 30, 20262.182.70+0.52+23.85%
Aug 7, 2026Jun 30, 20262.042.21+0.17+8.33%
May 8, 2026Mar 31, 20261.282.05+0.77+60.16%
Feb 27, 2026Dec 31, 20251.992.33+0.34+17.09%
Nov 7, 2025Sep 30, 20251.742.04+0.30+17.24%

Upgrades / downgrades

ANIP analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2026GuggenheimmainBuyBuy
Sep 23, 2026Oppenheimerinit—Perform
Aug 10, 2026GuggenheimmainBuyBuy
Aug 10, 2026Canaccord GenuitymainHoldHold
Jul 17, 2026Canaccord Genuityinit—Hold
Jul 10, 2026GuggenheimreitBuyBuy

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Princeton, New Jersey.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States

News

Your note

Sign in to keep a note on ANIP — it syncs with the Stock Master app.

Insider holders

ANIP insider holders
InsiderRelationLatest transactionDateShares held
CAREY STEPHEN P.Chief Financial OfficerSaleSep 28, 2026168,993
COOK MEREDITHGeneral CounselSaleOct 12, 202673,424
DAVIS KRISTAOfficerSaleMar 8, 202651,946
GASSERT CHADOfficerStock Award(Grant)Feb 25, 2026233,406
GUTWERG ORIOfficerSaleAug 9, 202675,534
HAUGHEY THOMAS JDirectorSaleJun 7, 202638,878

Institution ownership

ANIP institution ownership
Holder% heldSharesValueReported
Blackrock Inc.13.89%3,155,865218.16MSep 29, 2026
Soleus Capital Management, L.P.4.29%975,50067.44MSep 29, 2026
State Street Corporation4.19%950,97065.74MSep 29, 2026
American Century Companies Inc4.02%912,64763.09MSep 29, 2026
Vanguard Capital Management LLC3.98%904,70762.54MSep 29, 2026
Dimensional Fund Advisors LP3.21%728,74850.38MSep 29, 2026

Fund ownership

ANIP fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.28%1,198,64282.86MSep 29, 2026
American Century ETF Trust-Avantis U.S. Small Cap Value ETF3.28%745,30251.52MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.68%609,43342.13MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.33%529,87736.63MSep 29, 2026
OBERWEIS FUNDS-Oberweis Micro-Cap Fund1.13%256,30017.72MJun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund0.99%224,53615.52MAug 30, 2026